India · Delayed Price · Currency is INR Dr. Reddy's Laboratories Statistics
Total Valuation
BOM:500124 has a market cap or net worth of INR 997.15 billion. The enterprise value is 989.47 billion.
| Market Cap | 997.15B |
| Enterprise Value | 989.47B |
Important Dates
The last earnings date was Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
BOM:500124 has 832.52 million shares outstanding. The number of shares has decreased by -0.03% in one year.
| Current Share Class | 832.52M |
| Shares Outstanding | 832.52M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 26.81% |
| Owned by Institutions (%) | 66.70% |
| Float | 591.52M |
Valuation Ratios
The trailing PE ratio is 17.04 and the forward PE ratio is 18.90. BOM:500124's PEG ratio is 2.01.
| PE Ratio | 17.04 |
| Forward PE | 18.90 |
| PS Ratio | 2.91 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 4.07 |
| P/FCF Ratio | 31.28 |
| P/OCF Ratio | 16.95 |
| PEG Ratio | 2.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.98, with an EV/FCF ratio of 31.04.
| EV / Earnings | 16.88 |
| EV / Sales | 2.89 |
| EV / EBITDA | 10.98 |
| EV / EBIT | 13.94 |
| EV / FCF | 31.04 |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.85 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | 1.84 |
| Interest Coverage | 22.06 |
Financial Efficiency
Return on equity (ROE) is 17.36% and return on invested capital (ROIC) is 11.37%.
| Return on Equity (ROE) | 17.36% |
| Return on Assets (ROA) | 8.78% |
| Return on Invested Capital (ROIC) | 11.37% |
| Return on Capital Employed (ROCE) | 18.11% |
| Revenue Per Employee | 12.30M |
| Profits Per Employee | 2.11M |
| Employee Count | 27,811 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, BOM:500124 has paid 17.92 billion in taxes.
| Income Tax | 17.92B |
| Effective Tax Rate | 23.52% |
Stock Price Statistics
The stock price has decreased by -4.20% in the last 52 weeks. The beta is 0.33, so BOM:500124's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -4.20% |
| 50-Day Moving Average | 1,269.03 |
| 200-Day Moving Average | 1,235.23 |
| Relative Strength Index (RSI) | 33.92 |
| Average Volume (20 Days) | 311,657 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:500124 had revenue of INR 342.15 billion and earned 58.62 billion in profits. Earnings per share was 70.30.
| Revenue | 342.15B |
| Gross Profit | 193.08B |
| Operating Income | 70.83B |
| Pretax Income | 76.19B |
| Net Income | 58.62B |
| EBITDA | 88.67B |
| EBIT | 70.83B |
| Earnings Per Share (EPS) | 70.30 |
Balance Sheet
The company has 69.81 billion in cash and 58.54 billion in debt, giving a net cash position of 11.27 billion or 13.54 per share.
| Cash & Cash Equivalents | 69.81B |
| Total Debt | 58.54B |
| Net Cash | 11.27B |
| Net Cash Per Share | 13.54 |
| Equity (Book Value) | 362.08B |
| Book Value Per Share | 430.61 |
| Working Capital | 128.59B |
Cash Flow
In the last 12 months, operating cash flow was 58.82 billion and capital expenditures -26.94 billion, giving a free cash flow of 31.88 billion.
| Operating Cash Flow | 58.82B |
| Capital Expenditures | -26.94B |
| Free Cash Flow | 31.88B |
| FCF Per Share | 38.29 |
Margins
Gross margin is 56.43%, with operating and profit margins of 20.70% and 17.13%.
| Gross Margin | 56.43% |
| Operating Margin | 20.70% |
| Pretax Margin | 22.27% |
| Profit Margin | 17.13% |
| EBITDA Margin | 25.92% |
| EBIT Margin | 20.70% |
| FCF Margin | 9.32% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.67%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 0.67% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 11.36% |
| Buyback Yield | 0.03% |
| Shareholder Yield | 0.69% |
| Earnings Yield | 5.88% |
| FCF Yield | 3.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Oct 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
BOM:500124 has an Altman Z-Score of 5.69 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.69 |
| Piotroski F-Score | 4 |